Skip to content
APOAPOAPORIS35RIS35RIS35

Drawing based on the description in the official product monograph. No photo yet.

“6 . DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING. . Table 1 -. Dosage Forms, Strengths,. Composition and Packaging Route of Administration Oral Dosage Form / Strength/Composition Tablet / 35 mg risedronate sodium (as risedronate sodium hemipentahydrate) Non-medicinal Ingredients Anhydrous lactose, colloidal silicon dioxide, crospovidone, hydroxypropyl cellulose, hydroxypropyl methylcellulose”

APO RIS35 pill

Pill with imprint APO RIS35 is red & yellow, oval and has been identified as Risedronate Sodium Hemipentahydrate 35 mg. It is used for osteoporosis (weak bones). It is supplied by Apotex Inc.

Sold in Canada

Risedronate Sodium Hemipentahydrate 35 mg

Brand
Apo-Risedronate
Imprint
APO RIS35
Strength
35 mg
Used for
Osteoporosis (weak bones)
Color
Red, Yellow
Shape
Oval
Form
Tablet
Manufacturer
Apotex Inc
Sold in
Canada
DIN
02353687

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Risedronate pills and guides

What is Risedronate used for?

Risedronate is used for osteoporosis (weak bones).

Official uses from the US prescribing label

Postmenopausal Osteoporosis

Risedronate sodium delayed-release is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, risedronate sodium has been shown to reduce the incidence of vertebral fractures and a composite endpoint of nonvertebral osteoporosis-related fractures.

Important Limitations of Use

The optimal duration of use has not been determined. The safety and effectiveness of Risedronate sodium delayed-release for the treatment of osteoporosis are based on clinical data of one year duration. All patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. Patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. Patients who discontinue therapy should have their risk for fracture re-evaluated periodically.

From the FDA-approved label on DailyMed (published May 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows APO RIS35. The parts can be split between the two sides, so turn the pill over and check both.
  • It is red & yellow, oval.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as Apo-Risedronate by Apotex Inc.

In Canada: prescription only.

Ingredients

Active: Risedronate Sodium (Risedronate Sodium Hemipentahydrate)

Other pills with imprint APO RIS 35

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Risedronate pills